Albireo PPandE Turnover from 2010 to 2023

Summary

ALBODelisted Stock

USD 44.15 0.75 1.67%

Albireo Pharma PPandE Turnover yearly trend continues to be very stable with very little volatility. PPandE Turnover is likely to drop to 67.56. During the period from 2010 to 2023, Albireo Pharma PPandE Turnover quarterly data regression pattern had sample variance of 706.94 and median of 75.30. Albireo Pharma Weighted Average Shares is very stable at the moment as compared to the past year. Albireo Pharma reported last year Weighted Average Shares of 22.1 Million. As of 1st of April 2023, Weighted Average Shares Diluted is likely to grow to about 23.8 M, while Consolidated Income is likely to drop (33 M).

Check Albireo Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Albireo main balance sheet or income statement drivers, such as Direct Expenses of 1.2 M, Cost of Revenue of 1.2 M or Gross Profit of 48.7 M, as well as many exotic indicators such as Long Term Debt to Equity of 0.0502, PPandE Turnover of 67.56 or Receivables Turnover of 6.79. Albireo financial statements analysis is a perfect complement when working with Albireo Pharma Valuation or Volatility modules. It can also supplement various Albireo Pharma Technical models . Check out Trending Equities.

Albireo PPandE Turnover Breakdown

Showing smoothed PPandE Turnover of Albireo Pharma with missing and latest data points interpolated. Albireo Pharma's PPandE Turnover historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Albireo Pharma's overall financial position and show how it may be relating to other accounts over time.

PPandE Turnover

10 Years Trend

Down

Pretty Stable

Compare to Others All Fundamentals

PPandE Turnover

Timeline

Albireo PPandE Turnover Regression Statistics

	Arithmetic Mean	61.20
	Geometric Mean	32.43
	Coefficient Of Variation	43.45
	Mean Deviation	20.51
	Median	75.30
	Standard Deviation	26.59
	Sample Variance	706.94
	Range	81.43
	R-Value	(0.29)
	Mean Square Error	701.54
	R-Squared	0.08
	Significance	0.31
	Slope	(1.84)
	Total Sum of Squares	9,190

Albireo PPandE Turnover History

	2023	67.56
	2022	81.44
	2021	70.82
	2020	15.41
	2019	24.58
	2018	69.81
	2017	0.0101

About Albireo Pharma Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Albireo Pharma income statement, its balance sheet, and the statement of cash flows. Albireo Pharma investors use historical funamental indicators, such as Albireo Pharma's PPandE Turnover, to determine how well the company is positioned to perform in the future. Although Albireo Pharma investors may use each financial statement separately, they are all related. The changes in Albireo Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Albireo Pharma's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Albireo Pharma Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Albireo Pharma. Please read more on our technical analysis and fundamental analysis pages.

		Last Reported	Projected for 2023
	PPandE Turnover	81.44	67.56

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Albireo Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Albireo Pharma's short interest history, or implied volatility extrapolated from Albireo Pharma options trading.

Pair Trading with Albireo Pharma

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Albireo Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Albireo Pharma will appreciate offsetting losses from the drop in the long position's value.

Moving against Albireo Pharma

-	0.83	VALN	Valneva SE ADR	Report 4th of May 2023	Pair Corr
-	0.68	MDWD	Mediwound	Report 16th of May 2023	Pair Corr
-	0.67	CLVSQ	Clovis Oncology		Pair Corr
-	0.66	MDGL	Madrigal Pharmaceuticals	Report 8th of May 2023	Pair Corr
-	0.63	DICE	Dice Molecules Holdings	Report 11th of May 2023	Pair Corr

The ability to find closely correlated positions to Albireo Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Albireo Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Albireo Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Albireo Pharma to buy it.

The correlation of Albireo Pharma is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Albireo Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Albireo Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Albireo Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Check out Trending Equities. Note that the Albireo Pharma information on this page should be used as a complementary analysis to other Albireo Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Consideration for investing in Albireo Stock

If you are still planning to invest in Albireo Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Albireo Pharma's history and understand the potential risks before investing.

	Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets
	Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
	Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges
	Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments
	ETF Directory Find actively traded Exchange Traded Funds (ETF) from around the world
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2023 Macroaxis LLC